SARS-CoV-2 vaccine (S omicron variant) (EuBiologics)

N/A

Report date: 2025/01/26 17:04:37

Base Information

Drug NameSARS-CoV-2 vaccine (S omicron variant) (EuBiologics)

Drug Alias NameSARS-CoV-2 vaccine (EuBiologics)

ClassificationVaccines > Application > Prophylactic vaccineBiologics > Protein drugs > Recombinant protein

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesEubiologics Co Ltd

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsCoronavirus Disease 2019 (COVID-19)

Inactive IndicationsN/A

ATC CodeN/A